JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Original Article DOI : 10.7860/JCDR/2013/7019.3760
Year : 2013 | Month : Dec | Volume : 7 | Issue : 12 Full Version Page : 2788 - 2792

A Cross-sectional Study of Clinical, Histopathological and Direct Immunofluorescence Spectrum of Vesiculobullous Disorders

Arundhathi S.1, Ragunatha S.2, Mahadeva K.C.3

1 Assistant Professor, Department of Pathology, Sri Siddhartha Medical College, Agalakote, Tumkur-572107, Karnataka, India.
2 Associate Professor, Department of Dermatology, Venereology and Leprosy, Sri Siddhartha Medical College, Agalakote, Tumkur-572107, Karnataka, India.
3 Professor and Head, Department of Pathology, M.S. Ramaiah Medical College, Bangalore, Karnataka, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Arundhathi S., Assistant Professor, Department of Pathology, Sri Siddhartha Medical College, Tumkur-572107, Karnataka, India.
Phone: 9449670559,
E-mail: arundhathi19@yahoo.co.in
Abstract

Background: Accurate diagnosis of vesiculobullous lesions of skin requires evaluation of clinical, histopathologic and immunofluorescence findings.

Methods: A cross-divtional study of 68 patients to evaluate the clinical, histopathological and direct immunofluorescence (DIF) features in the diagnosis of cutaneous vesiculobullous disorders. The patients with vesiculobullous lesions were subjected to clinical examination regarding socio-demographic and clinical data. Two biopsy specimens were taken, one from intact vesicle for histopathological study and another from perilesional normal looking skin or oral mucosa for DIF.

Results: Vesiculobullous lesions constituted 22.08% of total number of skin biopsies. The most common clinical diagnosis was pemphigus vulgaris (PV) in 36 cases, followed by bullous pemphigoid (BP) in 8 cases, pemphigus foliaceous (PF) in 6 cases, and dermatitis herpetiformis (DH) in 4 cases. Characteristic histopathological features were present in 26 cases of PV, 9 cases of BP and 4 cases of PF, and 17.7% showed non- specific changes. DIF was positive in 24 cases of PV, 9 cases of BP and 3 cases of PF, and negative in 34.92% of cases.

Conclusion: Clinical, histopathological and DIF features together or in combination help in the final diagnosis of vesiculobullous disorders. Individually, none of these methods are diagnostic in each and every case.

Keywords

Introduction

Vesiculobullous disorders represent a heterogenous group of dermatoses with protean manifestations. They have remarkable impact on the patient and their family, and have severe economic consequences. The diseases have been the subject of intensive investigation in recent years [1].

Pathologic evaluation of blisters involves systematic analysis, which includes the blister separation plane, the mechanism of blister formation and the character of the inflammatory infiltrate, including its presence or absence [2]. Recent advances in investigative dermatology have created new horizons. The most important techniques for the investigation of patients with vesiculobullous disease are conventional histopathology and confirmative tests like direct and indirect immunofluorescence [1].

Immunofluorescence has greatly contributed to the diagnosis, treatment and understanding of the pathophysiology of vesiculobullous lesions of skin [3]. It is also an important prognostic tool as positive direct immunofluorescence (DIF) findings in patients in remission predict early relapse of disease [4]. Research techniques such as immunoblotting and immunoelectron microscopy may refine the diagnosis in the individual patient. However, these investigations are available only in advanced research laboratories. Even DIF is done only in a few centres in developing countries like India. With the availability of transport media like Michel’s media, majority of dermatologists can have access to DIF. Therefore, this study was undertaken to evaluate the clinical features, histopathology and DIF findings of various vesiculobullous disorders of the skin for their role in diagnosis.

Material and Methods

A cross-sectional, descriptive hospital based study of clinical, histopathological and DIF features of vesiculobullous diseases was conducted on patients attending department of dermatology and pathology of tertiary care hospital over a period of two year.

After obtaining institutional ethical committee clearance and written consent, all the patients attending out-patient department of dermatology were screened for presence of vesiculobullous lesions. In patients with vesiculobullous lesions, detailed history and clinical examination was done with particular reference to age, gender, morphology of lesions, site of involvement and clinical tests such as Nikolsky’s sign and Bulla spread sign. The patients with clinical features suggestive of immunobullous, mechanobullous, severe adverse cutaneous drug reactions or metabolic disorders were included in the study as these disorders show varied clinical manifestations. Histopathology and DIF in these disorders help in the final diagnosis, exclusion of differential diagnosis and determining course of the disease and their response to treatment. Vesiculobullous lesions secondary to infections, eczemas and burns (chemical or thermal) were excluded from the study as these disorders present with characteristic clinical features, and histopathology and DIF are not the main diagnostic methods.

In all the patients, punch biopsy from the lesional skin or oral mucosa preferably including intact vesicle was performed for histopathological study and another biopsy from perilesional normal looking skin or oral mucosa was taken for DIF. Of the two biopsies, one was sent in normal saline or Michel’s medium for DIF and the other in 10% neutral buffered formalin for hematoxylin and eosin staining (H and E).

Histopathological diagnosis was based on level of blister separation, inflammatory infiltrate, altered keratinocytes such as acanthocytes and dyskeratotic cells and pattern of arrangement of keratinocytes e.g. row of tombstone, dilapidated brick wall appearance. Based on these features the vesiculobullous diseases were divided into subcorneal [PF, Pemphigus Erythematosus (PE), Subcorneal pustular dermatosis (SCPD)], intraspinous [toxic epidermal necrosis (TEN), erythema multiforme (EM)], suprabasal (PV, Hailey- Hailey disease) and subepidermal [BP, DH, bullous systemic lupus erythematosis (BSLE)] blistering disorders.

The DIF result was based on site (intercellular, along basement membrane zone or dermal papillae), type (IgG, IgM, IgA or C3), pattern (granular or linear) and intensity of deposition of immune reactants.

Results

During the period of 24 months, 68 biopsy specimens of vesiculobullous lesions of skin were received which constituted 22.08% of all skin biopsies. Majority of patients presented between 40-49 years of age (20 %). Youngest patient was two year old and oldest of 83 years. Female patients were more in number with male: female ratio of 1:1.27.

PV (18/26) and BP (7/11) showed lesions all over the body. Oral mucosal involvement was present in 84.6% (22/26) cases in PV and 18.2% cases in BP. Half the number of patients of PE, PF and BSLE had lesions over the trunk. Involvement of limbs was seen in 18.2% of BP and 100% of IBR cases.

In BP, EB, EM and herpes gestationis (HG) 100% of cases showed vesicle and/or bulla. In PE, SCPD and BSLE 50% of the cases showed vesicles. In PV 76.9% of cases showed vesicles and/or bulla. Nikolsky’s sign and Bulla spread sign was positive in 84.6% and 19.23% of PV patients and 50% and 25% of PF patients respectively.

Clinical provisional diagnosis and histopathological features of different vesiculobullous lesions are shown in [Table/Fig-1,2,3,4,56]. Predominant inflammatory infiltrate consisted of neutrophils in PV. BP showed presence of subepidermal blisters containing eosinophils.

Pemphigus vulgaris. Suprabasal blister, acantholytic cells and tomb stone appearance (H&E, 40X)

Bullous pemphigoid. Subepidermal bulla filled with eosinophils (H & E, 40X)

Pemphigus foliaceous. Subcorneal bulla with acanthocytes (H &E, 10X)

Discordance between clinical, histopathological and DIF findings

DiseaseClinical diagnosisHistopathological diagnosisDIFFinal diagnosis#Percentage (n=68)
PositiveNegative
PV36262422638.2
PF6431405.8
PE2120202.9
BP*89911116.2
EBA2101101.5
Vasculitis100100
DH400000
Darier’s disease±11--101.5
SJS100000
BSLE1220202.9
IBR*3201202.9
PCT ±11--101.5
IgA pemphigus100000
Hailey-Hailey disease1101101.5
EM0202202.9
Non-specific*0120111217.7
HG0110101.5
SCPD0202202.9

Note: * - DIF not done in one case; ± - DIF not done, # - final diagnosis based on histopathology and DIF. PV- Pemphigus vulgaris, PF – Pemphigus foliaceus, PE – Pemphigus erythematosus, BP- Bullous pemphigoid, EBA- Epidermolysis bullosa acquisita, DH- Dermatitis herpetiformis, SJS- Steven Johnson syndrome, BSLE- Bullous systemic lupus erythematosus, IBR- Insect bite reaction, PCT – Porphyria cutanea tarda, EM – Erythema multiforme, HG- Herpes gestationis, SCPD- Subcutaneous pustular dermatosis


Level of blister in vesiculobullous disorders

Final diagnosisSuprabasalSubcornealDermoepidermal junctionIntraepidermalNo seperation
PV25(96.2%)0001(3.8%)
PF4(100%)000
PE01(50%)001(50%)
BP1(9.1%)08(72.3%)1(9.1%)1(9.1%)
EBA01(100%)000
EM001(50%)01(50%)
Non Specific1(8.3%)01(8.3%)2(16.7%)8(66.7%)
Darier’s1(100%)0000
Herpes Gestationis001(100%)00
Insect Bite001(50%)1(50%)0
PCT00001(100%)
Hailey- Hailey1(100%)0000
SCPD02(100%)000
BSLE002(100%)00

Note: PV- Pemphigus vulgaris, PF – Pemphigus foliaceus, PE – Pemphigus erythematosus

BP- Bullous pemphigoid, EBA- Epidermolysis bullosa acquisita, EM – Erythema multiforme

PCT – Porphyria cutanea tarda, SCPD- Subcutaneous pustular dermatosis, BSLE- Bullous systemic lupus erythematosus


Histopathological findings in vesiculobullous disorders

Final diagnosisEpidermal changes n(%)
Tomb stone appearanceVilliHyperkeratosisAcanthosisDyskeratosisAcanthocytes
PV23(88.5)10(38.5)2(7.7)3(11.5)020(76.9)
PF01(25)001(25)3(75)
PE000002(100)
BP000000
EBA000000
EM001(50)1(50)00
Non-specific1(8.3)04(33.3)7(58.3)00
Darier’s disease01(100)1(100)1(100)1(100)1(100)
Herpes Gestationis0001(100)00
Insect Bite0001(50)01(50)
PCT001(100)1(100)00
Hailey- Hailey disease01(100)0001(100)
SCPD0001(50)01(50)
BSLE001(50)000

Note: PV- Pemphigus vulgaris, PF – Pemphigus foliaceus, PE – Pemphigus erythematosus, BP- Bullous pemphigoid, EBA- Epidermolysis bullosa acquisita, EM – Erythema multiforme, PCT – Porphyria cutanea tarda, SCPD- Subcutaneous pustular dermatosis, BSLE- Bullous systemic lupus erythematosus


DIF pattern of deposition of immune reactants in different vesiculobullous disorders are shown in [Table/Fig-7,Table/Fig-8 and 9]. Five cases showed discordance between histopathological diagnosis and DIF findings. DIF was negative in all the five cases. In these cases, histopathological findings were diagnostic.

Antibody deposition in direct immunofluorescence

Final diagnosisAntibody deposition
IgGIgMIgAC3Both IgG and C3Negative
PV15(57.7%)0009(34.6%)2(7.7%)
PF2(50%)0001(25%)1(25%)
PE2(100%)00000
BP*1(9.1%)003(27.3%)5(45.5%)1(9.1%)
EBA000001(100%)
EM000002(100%)
Non-specific *0000011(100%)
Darier’s ±000000
Herpes Gestationis0001(100%)00
Insect Bite*000001(100%)
PCT ±000000
Hailey- Hailey000001(100%)
SCPD000002(100%)
BSLE0001(50%)1(50%)0

Note: *- DIF not done in one case, ±- DIF not done

PV- Pemphigus vulgaris, PF – Pemphigus foliaceus, PE – Pemphigus erythematosus, BP- Bullous pemphigoid, EBA- Epidermolysis bullosa acquisita, EM – Erythema multiforme, PCT – Porphyria cutanea tarda, SCPD- Subcutaneous pustular dermatosis, BSLE- Bullous systemic lupus erythematosus


Pemphigus vulgaris. Deposition of IgG in intercellular spaces giving a fish net appearance (DIF, 40X)

Bullous pemphigoid. Linear deposition of C3 along the basement membrane zone (DIF, 4X)

Discordance between clinical, histopathological and DIF findings were noted [Table/Fig-4 and 10]. Certain disorders like BSLE, SCPD were not part of initial clinical diagnosis. Similarly, all clinically suspected cases of DH were not confirmed either by histopathology or DIF. The final diagnosis was based on histopathology and DIF findings [Table/Fig-4].

Discordance between clinical and final diagnosis

Clinical diagnosis (n)Histopathological diagnosis in conjunction with DIF (final diagnosis)
Non specificBPPFSCPDPVBSLEEMHG
PV (10)232--111
Vasculitis(1)1-------
BP (1)1-------
DH (4)31------
PF (4)10-21---
EBA (1)1-------
SJS (1)------1-
Insect bite (1)1-------
IgA pemphigus (1)----1---

Note: PV- Pemphigus vulgaris, BP- Bullous pemphigoid, DH- Dermatitis herpetiformis, PF – Pemphigus foliaceus, EBA- Epidermolysis bullosa acquisita, SJS- Steven Johnson syndrome


Discussion

Though, various primary cutaneous diseases present clinically with vesiculobullous lesions, their etiology, pathogenesis, severity and course differs. Therefore, accurate diagnosis of these diseases is essential for appropriate management to avoid or minimize associated morbidity and mortality.

Clinically, all the patients with vesiculobullous diseases may not present with classical morphology and distribution of the lesions. The number of patients presenting with clinical features like vesicles and bullae, involvement of mucous membranes, Nikolsky’s sign and Bulla spread sign is different in various studies conducted in India [5]. The difference may be due to prevalence of the diseases, severity and stage of the disease at presentation and status of the treatment. Oral mucosa can be only site of involvement in the early stage of pemphigus vulgaris [6] as noted in the present study. In these clinical scenarios where clinical diagnosis is difficult, histopathology and DIF of biopsy specimen will help in arriving at final diagnosis.

All the vesiculobullous diseases show specific histopathological changes which are demonstrated only when early intact vesicle or bulla is included in the biopsy specimen. Similar to clinical features, the number of specimen showing specific histopathological changes is different in various studies conducted in India. In PV, suprabasal separation has been observed in 81.4 [5] - 97% [6], a row of tomb stone appearance was seen in 41.8% [5], acanthocytes in 93 [5]-97% [6], and inflammatory cells in bullous cavity in 53.5 [5]-97% [6] of specimens. In PF, subcorneal separation has been observed in 60% and acanthocytes in 96% of specimen [5]. In BP, subepidermal separation has been observed in 72.3% of specimen which is less compared to study by Nishioka K et al., [7]. These variations may be due to differences in site or type of lesion selected for biopsy. The histopathological changes noted in SCPD and BSLE were consistent with other studies [8,9]. In some cases, the histopathological changes can be non-specific. In the present study, non-specific changes were seen in cases clinically diagnosed as dermatitis herpetiformis and pemphigus vulgaris. In all these patients the clinical presentation was either excoriated papules as in the former or erosions as in the latter. If the histopathological study is non-confirmatory and clinical features strongly suggestive of one of the immunobullous disease, DIF study is recommended.

DIF identifies the deposition of immune reactants like antibodies and complements in the specimen. Hence, DIF is helpful in diagnosis of immunobullous diseases as intraepidermal and subepidermal. DIF positivity has been reported in 100% [10] and 93.28% [11] of PV cases, 100% [4, 10] and 88% [11] of PF cases and 100% [12,13] of cases of BP. As the DIF finding of PF is similar to PV, histopathology helps in differentiating PV from PF. In PE, DIF was helpful as both PE and PF show similar histopathology findings. PE usually shows granular depositions in basement membrane zone (BMZ) along with intercellular deposits in 80% of cases. The final diagnosis of PE was made based on classical malar rash in one case and positive antinuclear antibody titre in other.

In the present study, two cases with clinical and histopathological features of PV showed negative DIF. Selection of biopsy site, treatment status, and technical errors may result in false negativity of DIF. In the absence of these factors, the negative DIF indicates prolonged remission. Negative DIF helps in differentiating SCPD, Hailey-Hailey disease and Darier’s disease from intraepidermal immunobullous diseases. In the present study, negative DIF also helped to exclude DH.

In the present study, discordance between clinical, histopathological and DIF features has been noted [Table/Fig-4 and 10] as these features are affected by duration of the disease, stage of disease at presentation, selection of biopsy site and treatment status. This underlines the importance of considering all these features in combination to arrive at final diagnosis.

Conclusion

Clinical examination is the initial step in making a diagnosis of vesiculobullous disorders. Histopathological examination and DIF are required for making a definitive diagnosis. DIF is helpful in scenarios where clinical and/ or histopathological features are inconclusive. In comparison to DIF, histopathology remains the cornerstone in differentiating PV from PF. Hence, clinical, histopathological and DIF features are considered together to arrive at final diagnosis as these methods may not be diagnostic individually in each and every case.

Note: * - DIF not done in one case; ± - DIF not done, # - final diagnosis based on histopathology and DIF. PV- Pemphigus vulgaris, PF – Pemphigus foliaceus, PE – Pemphigus erythematosus, BP- Bullous pemphigoid, EBA- Epidermolysis bullosa acquisita, DH- Dermatitis herpetiformis, SJS- Steven Johnson syndrome, BSLE- Bullous systemic lupus erythematosus, IBR- Insect bite reaction, PCT – Porphyria cutanea tarda, EM – Erythema multiforme, HG- Herpes gestationis, SCPD- Subcutaneous pustular dermatosisNote: PV- Pemphigus vulgaris, PF – Pemphigus foliaceus, PE – Pemphigus erythematosusBP- Bullous pemphigoid, EBA- Epidermolysis bullosa acquisita, EM – Erythema multiformePCT – Porphyria cutanea tarda, SCPD- Subcutaneous pustular dermatosis, BSLE- Bullous systemic lupus erythematosusNote: PV- Pemphigus vulgaris, PF – Pemphigus foliaceus, PE – Pemphigus erythematosus, BP- Bullous pemphigoid, EBA- Epidermolysis bullosa acquisita, EM – Erythema multiforme, PCT – Porphyria cutanea tarda, SCPD- Subcutaneous pustular dermatosis, BSLE- Bullous systemic lupus erythematosusNote: *- DIF not done in one case, ±- DIF not donePV- Pemphigus vulgaris, PF – Pemphigus foliaceus, PE – Pemphigus erythematosus, BP- Bullous pemphigoid, EBA- Epidermolysis bullosa acquisita, EM – Erythema multiforme, PCT – Porphyria cutanea tarda, SCPD- Subcutaneous pustular dermatosis, BSLE- Bullous systemic lupus erythematosusNote: PV- Pemphigus vulgaris, BP- Bullous pemphigoid, DH- Dermatitis herpetiformis, PF – Pemphigus foliaceus, EBA- Epidermolysis bullosa acquisita, SJS- Steven Johnson syndrome

References

[1]Wojnarowska F, Venning VA, Immunobullous diseases. In: Burns T, Brethnach S, Cox N, Griffiths C, ed Rook’s Textbook of Dermatology 2010 8th editionOxfordWells Blackwell:40.1-40.62.  [Google Scholar]

[2]Wu H, Schapiro B, Harrist TJ, Noninfectious vesiculobullous and vesiculopustular diseases. In: Elder D, Elenitsas R, Johnson BL, Murphy GF, ed Lever’s histopathology of the skin 2005 9th editionPhiladelphiaLippincott Williams and Wilkins:243-91.  [Google Scholar]

[3]Huilgol SC, Bhogal BS, Black MM, “Immunofluorescence of immunobullous disorders part one: methodology” Indian J Dermatol Venereol Leprol 1995 61:187-95.  [Google Scholar]

[4]Inchara YK, Rajalakshmi T, “Direct immunofluorescence in cutaneous vesiculobullous lesions” Indian J Pathol Microbiol 2007 50(4):730-2.  [Google Scholar]

[5]Arya SR, Valand AG, Krishna K, A clinico-pathological study of 70 cases of pemphigus Indian J Dermotol Venereol Leprol 1999 65(4):168-71.  [Google Scholar]

[6]Handa F, Aggarwal RR, Kumar R, A clinical study of 85 cases of pemphigus Indian J Dermotol Venereol Leprol 1973 39(3)(106-11)  [Google Scholar]

[7]Nishioka K, Hashimoto K, Katayama I, Sarashi C, Kubo T, Sano S, Eosinophilic spongiosis in bullous pemphigoid Arch Dermotol 1984 120:1166-8.  [Google Scholar]

[8]Mittal RR, Singla A, Gill SS, Subcorneal pustular dermatosis during summer months Indian Journal of Dermatology Venerology Leprology 1993 59:288-9.  [Google Scholar]

[9]Parviainen Karen C, Lesher JL, Bullous SLE The Internet Journal of Dermatology 2003 2(1)  [Google Scholar]

[10]Kanwar AJ, De D, Pemphigus in India Indian J Dermatol Venereol Leprol 2011 77:439-49.  [Google Scholar]

[11]Chams-Davatchi C, Valikhani M, Daneshpazhooh M, Esmaili N, Balighi K, Hallaji Z, Pemphigus: analysis of 1209 cases Int J Dermatol 2005 44:470-6.  [Google Scholar]

[12]Kippes W, Schmidt E, Roth A, Rzany B, Brocker EB, Immunopathologic changes in 115 patients with bullous pemphigoid Hautarz 1999 50(12):866-72.  [Google Scholar]

[13]Cozzani E, Parodi A, Rebora A, Delmonte S, Barile M, Nigro A, Bullous pemphigoid in Liguria: a 2-year survey J Eur Acad Dermatol Venereol 2001 15(4):317-9.  [Google Scholar]